Atlas Trials

A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

Clinical trial NCT07211776 · RECRUITING

Trial details

NCT number
NCT07211776
Sponsor
Zai Lab (Shanghai) Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Thyroid Eye Disease (TED)
Start date
2025-12-05
Primary completion
2027-03-14
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.